What started as a trickle of data is turning into a rivulet, and may become a stream before long as more and more researchers are testing the idea that β-secretase enzyme activity in cerebrospinal ...
Previous studies report that mice lacking BACE1 have seizures, but disagree about why. Now, German scientists led by Christian Alzheimer and Tobias Huth of Friedrich-Alexander-Universität ...
Researchers from the Cleveland Clinic have reversed the development of amyloid plaque in mice with Alzheimer’s disease by gradually depleting their levels of BACE1. The study buoys hope that targeting ...
Researchers working at Lerner Research Institute, Cleveland Clinic reported in the November 8, 2021, issue of Nature Cancer that an inhibitor of the beta-amyloid producing enzyme, BACE1, could ...
Researchers have found that gradually depleting an enzyme called BACE1 completely reverses the formation of amyloid plaques in the brains of mice with Alzheimer's disease, thereby improving the ...
Merck ($MRK) has posted a roundup of data generated to date on its BACE1 inhibitor in Alzheimer’s disease tests and trials. The package includes results from a ...
In brains with sporadic Alzheimer disease (AD), the critical enzyme beta-secretase1 (BACE1) is known to be elevated. Scientists have now found increased levels of BACE1 in brains with mild cognitive ...
A new study has successfully reversed both the biological and behavioral hallmarks of Alzheimer's disease in mouse models. The research found that slowly depleting the presence of a certain enzyme can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results